CC BY-NC-ND 4.0 · World J Nucl Med 2021; 20(01): 99-101
DOI: 10.4103/wjnm.WJNM_28_20
Case Report

Solitary late metastasis of primary renal cell carcinoid tumor to the extraocular muscles imaged with indium-111 octreotide

Philip Dempsey
Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
,
Martin O'Connell
Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
,
Ferdia Bolster
Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
› Author Affiliations

Abstract

A 75-year-old male presented with right eye pain and proptosis. His history was significant for renal cell carcinoma treated with left nephrectomy 2 years previously. Computed tomography (CT) imaging demonstrated a 1.6-cm enhancing lesion in the right retrobulbar space. Surgical biopsy revealed a low-grade metastatic carcinoid tumor. At retrospective review, the primary renal lesion from 2 years prior was rediagnosed as consistent with a renal carcinoid tumor. Indium-111 octreotide single photon emission CT/CT imaging demonstrated a solitary metastasis within the right extraocular muscles. The patient subsequently developed additional metastases within the remaining right kidney and lung.

Financial support and sponsorship

Nil.




Publication History

Received: 07 April 2020

Accepted: 01 May 2020

Article published online:
30 March 2022

© 2021. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Intenzo CM, Jabbour S, Lin HC, Miller JL, Kim SM, Capuzzi DM, et al. Scintigraphic imaging of body neuroendocrine tumors. Radiographics 2007;27:1355-69.
  • 2 Romero FR, Rais-Bahrami S, Permpongkosol S, Fine SW, Kohanim S, Jarrett TW. Primary carcinoid tumors of the kidney. J Urol 2006;176:2359-66.
  • 3 Omiyale AO, Venyo AK. Primary carcinoid tumour of the kidney: A review of the literature. Adv Urol 2013;2013:579396-11.
  • 4 Korkmaz T, Seber S, Yavuzer D, Gumus M, Turhal NS. Primary renal carcinoid: Treatment and prognosis. Crit Rev Oncol Hematol 2013;87:256-64.
  • 5 Lane BR, Chery F, Jour G, Sercia L, Magi-Galluzzi C, Novick AC, et al. Renal neuroendocrine tumours: A clinicopathological study. BJU Int 2007;100:1030-5.
  • 6 Matsuo T, Ichimura K, Tanaka T, Takenaka T, Nakayama T. Neuroendocrine tumor (carcinoid) metastatic to orbital extraocular muscle: Case report and literature review. Strabismus 2010;18:123-8.
  • 7 Bergeret S, Charbit J, Ansquer C, Bera G, Chanson P, Lussey-Lepoutre C. Novel PET tracers: Added value for endocrine disorders. Endocrine 2019;64:14-30.
  • 8 Naswa N, Sharma P, Kumar R, Malhotra A, Bal C. Usual and unusual neuroendocrine tumor metastases on (68)Ga-DOTANOC PET/CT: A pictorial review. Clin Nucl Med 2013;38:e239-45.
  • 9 Gupta A, Chazen JL, Phillips CD. Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature. AJNR Am J Neuroradiol 2011;32:1208-11.
  • 10 Scarsbrook AF, Ganeshan A, Statham J, Thakker RV, Weaver A, Talbot D, et al. Anatomic and functional imaging of metastatic carcinoid tumors. Radiographics 2007;27:455-77.